Similar articles

• Leprosy uveitis in the developing world.

  Rathinam SR. Rathinam SR. Int Ophthalmol Clin. 2010 Spring;50(2):99-111. doi: 10.1097/IIO.0b013e3181d2d5bb. Int Ophthalmol Clin. 2010. PMID: 20375865 Review. No abstract available.
• Pathology of eye in leprosy.

  Job CK, Ebenezer GJ, Thompson K, Daniel E. Job CK, et al. Indian J Lepr. 1998 Jan-Mar;70(1):79-91. Indian J Lepr. 1998. PMID: 9598408 Review. No abstract available.
• M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro.

  Nery JA, Sampaio EP, Galhardo MC, Perissé AR, Vieira LM, Salles AM, Sarno EN. Nery JA, et al. Indian J Lepr. 2000 Apr-Jun;72(2):155-67. Indian J Lepr. 2000. PMID: 11008656 No abstract available.
• Selective loss of Mycobacterium leprae responsiveness of circulating lymphocytes in primary neuritic leprosy.

  Nath I, Narayanan RB, Sathish M, Ahuja GK, Bhutani LK, Singh R. Nath I, et al. Lepr Rev. 1981 Mar;52(1):79-89. Lepr Rev. 1981. PMID: 7017320 No abstract available.
• Demonstration of Mycobacterium leprae and its viability in the peripheral blood of leprosy patients.

  Manja KS, Bedi BM, Kasturi G, Kirchheimer WF, Balasubrahmanyan M. Manja KS, et al. Lepr Rev. 1972 Dec;43(4):181-7. Lepr Rev. 1972. PMID: 4579979 No abstract available.